Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.100
-0.010 (-0.90%)
At close: Nov 22, 2024, 4:00 PM
1.080
-0.020 (-1.80%)
After-hours: Nov 22, 2024, 5:41 PM EST
Immunic Market Cap
Immunic has a market cap or net worth of $99.09 million as of November 22, 2024. Its market cap has increased by 88.38% in one year.
Market Cap
99.09M
Enterprise Value
40.91M
1-Year Change
88.38%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $99.09M, a decrease of -60.90%. That is a compound annual growth rate of -8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 94.60M | 39.73% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 99.17M |
| PetMed Express | 99.12M |
| Veru Inc. | 98.41M |
| Harvard Bioscience | 97.69M |
| Tiziana Life Sciences | 97.42M |
| Nuvectis Pharma | 96.41M |
| Regulus Therapeutics | 96.29M |
| Inotiv | 94.91M |